158 related articles for article (PubMed ID: 38256893)
1. In Silico Screening of Multi-Domain Targeted Inhibitors for PTK6: A Strategy Integrating Drug Repurposing and Consensus Docking.
Zhou Y; Wong MW
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256893
[TBL] [Abstract][Full Text] [Related]
2. Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain.
Hong E; Shin J; Kim HI; Lee ST; Lee W
J Biol Chem; 2004 Jul; 279(28):29700-8. PubMed ID: 15056653
[TBL] [Abstract][Full Text] [Related]
3. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
Kim HIe; Lee ST
J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.
Kim HIe; Jung J; Lee ES; Kim YC; Lee W; Lee ST
Biochem Biophys Res Commun; 2007 Nov; 362(4):829-34. PubMed ID: 17822667
[TBL] [Abstract][Full Text] [Related]
5. Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling.
Dwyer AR; Kerkvliet CP; Krutilina RI; Playa HC; Parke DN; Thomas WA; Smeester BA; Moriarity BS; Seagroves TN; Lange CA
Mol Cancer Res; 2021 Feb; 19(2):329-345. PubMed ID: 33172975
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of the auto-inhibition mechanism of nonreceptor tyrosine kinase PTK6.
Ko S; Ahn KE; Lee YM; Ahn HC; Lee W
Biochem Biophys Res Commun; 2009 Jun; 384(2):236-42. PubMed ID: 19401189
[TBL] [Abstract][Full Text] [Related]
7. Exon-intron structure of the human PTK6 gene demonstrates that PTK6 constitutes a distinct family of non-receptor tyrosine kinase.
Lee H; Kim M; Lee KH; Kang KN; Lee ST
Mol Cells; 1998 Aug; 8(4):401-7. PubMed ID: 9749526
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
[TBL] [Abstract][Full Text] [Related]
9. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
10. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.
Richard S; Yu D; Blumer KJ; Hausladen D; Olszowy MW; Connelly PA; Shaw AS
Mol Cell Biol; 1995 Jan; 15(1):186-97. PubMed ID: 7799925
[TBL] [Abstract][Full Text] [Related]
11. Role of the Brk SH3 domain in substrate recognition.
Qiu H; Miller WT
Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
[TBL] [Abstract][Full Text] [Related]
12. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
13. Purification and spectroscopic characterization of the human protein tyrosine kinase-6 SH3 domain.
Koo BK; Kim MH; Lee ST; Lee W
J Biochem Mol Biol; 2002 May; 35(3):343-7. PubMed ID: 12297019
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Non-peptide Small Molecule Allosteric Modulators of the Src-family Kinase, Hck.
Dorman HR; Close D; Wingert BM; Camacho CJ; Johnston PA; Smithgall TE
Front Chem; 2019; 7():822. PubMed ID: 31850311
[TBL] [Abstract][Full Text] [Related]
16. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
18. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
[TBL] [Abstract][Full Text] [Related]
19. Co-crystal structures of PTK6: With Dasatinib at 2.24 Å, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 Å resolution.
Thakur MK; Birudukota S; Swaminathan S; Battula SK; Vadivelu S; Tyagi R; Gosu R
Biochem Biophys Res Commun; 2017 Jan; 482(4):1289-1295. PubMed ID: 27993680
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution.
Thakur MK; Kumar A; Birudukota S; Swaminathan S; Tyagi R; Gosu R
Biochem Biophys Res Commun; 2016 Sep; 478(2):637-42. PubMed ID: 27480927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
